A new technology that dramatically improves the sensitivity of Magnetic Resonance techniques including those used in hospital scanners and chemistry laboratories has been developed by scientists at the University of York.
Tissue removal is currently the only way to verify suspicious lesions in the prostate. It is also a key requirement before treating prostate carcinomas. The standard biopsy is performed with transrectal ultrasound (TRUS) to guide the needle in the right direction.
The German Radiological Society, the congress organising body, expects over 7,000 participants from Germany and abroad at this year's event.
The role of magnetic resonance imaging (MRI) to assess the effect of therapy in patients with acute myocardial infarction was demonstrated in a series of papers presented at the 12th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR).
A new technology which dramatically improves the sensitivity of Magnetic Resonance techniques including those used in hospital scanners and chemistry laboratories has been developed by British scientists. The technique could replace current clinical imaging technologies that depend on the use of radioactive substances or heavy metals, which themselves create health concerns.
University of Utah researchers have found that delayed-enhancement magnetic resonance imaging (DE-MRI) holds promise for predicting treatment outcomes and measuring disease progression for patients with atrial fibrillation (AF), a little known heart rhythm disorder that affects more than 3.5 million Americans and causes more than 66,000 deaths a year. Their latest study on a novel application of…
Definiens, the number one Enterprise Image Intelligence company, launched its first computer-aided detection (CAD) application, Definiens LymphExpert at the annual European Congress of Radiology (ECR) in Vienna, Austria. Now commercially available for European radiologists, the application assists in tracking lymph nodes of interest, facilitating earlier detection of the metastatic spread of…
In a symposium organised by Bayer Schering Pharma at the 2009 European Congress of Radiology (ECR), the audience heard a series of four presentations on the potential advantages of high-signal-intensity contrast agents for MRI, focusing on gadobutrol (Gadovist). During the discussion, several claims made by the speakers were challenged and debated by ECR delegates.
André Hoppen, Sales Manager VR Medico, Berlin, Germany, kicked off the finance item at the HMS agenda with his lecture “Do you know the right financing strategy for your hospital?”
Within the last three decades, contrast-enhanced magnetic resonance breast imaging has gone through substantial developments, evolving to become the imaging modality with the highest sensitivity for breast cancer detection. The indication to perform breast MRI ranges widely, including high-risk patients, dense breast tissue and therapy monitoring under primary systemic therapy.
Early detection currently remains the most promising way to optimise the diagnosis and treatment of breast cancer, lower the mortality rate resulting from this disease, and improve patients' quality of life.
Dr Giorgio Rizzatto, who heads the Department of Diagnostic Imaging at ASS 2 Isontina (including the Gorizia and Monfalcone hospitals) in NE Italy, works with nine radiologists, who examine and report on 80,000 clinical and screening breast examinations annually.
Thanks to cell therapy, researchers have found new ways to understand and potentially treat heart diseases and degenerative conditions such as Parkinson's and cancer. The role of imaging is becoming more and more important, especially in understanding the action of transplanted cells in situ.
Siemens Healthcare exhibits its latest solutions in the field of Magnetic Resonance (MR) for Oncology at the European Radiology Congress ECR 2009 in Vienna. The syngo TimCT Oncology application enables not only comprehensive patient examinations within extreme short examination time possible, it can also eliminate the need for multiple examinations with other modalities.
Basic research and clinical patient care became separate disciplines in the 70s and 80s.
Uterine fibroids are the most common benign tumours in women. Treatment is only necessary if the fibroids cause pain and bleeding due to their size and position. Minimally-invasive fibroid embolisation is a gentle, efficient and long-lasting treatment for their removal, leaving the uterus intact. The first evaluations of several international long-term studies have indicated a high success rate…
'There is no proof that some new procedures are better than the conventional ones or than clinical examination'
The clear focus of the numerous lectures given at the International MRI Symposium was on cardiac imaging.
Switzerland - Magnetic resonance imaging (MRI) scans could become a more comfortable experience for patients because, by tinkering with the detection technique, researchers have freed up more space inside the machine.
The role of magnetic resonance imaging (MRI) to assess the effect of therapy in patients with acute myocardial infarction was demonstrated in a series of papers during the 12th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR), held in Orlando, Fla. USA (29 Jan - 1 Feb).
In Europe, when you think of medical imaging technology the obvious names spring to mind: Siemens, GE, Toshiba and Philips. However, Hitachi, already a world leader in permanent magnet MRI, and with a reputation in open MRI systems, has a keen eye on the European market. According to Jan Reijnen, the firm´s Product Manager for MRI/CT in Europe, Hitachi has already installed more than 5,000 open…
In the sixth in his series for European Hospital, Professor Stefan Schönberg (left) of the Institute of Clinical Radiology and Nuclear Medicine (IKRN), University Hospital Mannheim, Medical Faculty of Mannheim, University of Heidelberg, invited colleagues from Mannheim and Vienna for a round-table discussion on:
Big discussions are expected at the upcoming European Association of Urology (EAU) Congress in Stockholm* when urologist Dr Jochen Walz (right), of the Urological Department at the Institute Paoli-Calmettes, Marseilles, France, presents the forum: Imaging in Europe: Who, where, what, how many! and M F Coelho, of the European Society of Urological Imaging (ESUI) describes the Clinical utility of…
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
The role of women in radiology and the challenges they face were again the focus of a session — Women in Radiology: How to maximise their potential — at this year's ECR, when female and male radiologists discussed their work experiences and combining home and family life with demanding careers. A forum also discussed the family friendly approaches in various countries.